HUE049797T2 - Gyenge megoszlási kromatográfiás eljárás - Google Patents
Gyenge megoszlási kromatográfiás eljárásInfo
- Publication number
- HUE049797T2 HUE049797T2 HUE06738028A HUE06738028A HUE049797T2 HU E049797 T2 HUE049797 T2 HU E049797T2 HU E06738028 A HUE06738028 A HU E06738028A HU E06738028 A HUE06738028 A HU E06738028A HU E049797 T2 HUE049797 T2 HU E049797T2
- Authority
- HU
- Hungary
- Prior art keywords
- weak partitioning
- partitioning chromatography
- chromatography
- weak
- partitioning
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/30—Partition chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/32—Bonded phase chromatography
- B01D15/325—Reversed phase
- B01D15/327—Reversed phase with hydrophobic interaction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
- B01D15/3828—Ligand exchange chromatography, e.g. complexation, chelation or metal interaction chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66043705P | 2005-03-11 | 2005-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE049797T2 true HUE049797T2 (hu) | 2020-10-28 |
Family
ID=36992346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE06738028A HUE049797T2 (hu) | 2005-03-11 | 2006-03-10 | Gyenge megoszlási kromatográfiás eljárás |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US8067182B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1869065B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5199063B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR101660575B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN101175765A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006223180B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0608584B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2601062C (cg-RX-API-DMAC7.html) |
| CR (1) | CR9377A (cg-RX-API-DMAC7.html) |
| DK (1) | DK1869065T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2797480T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1210476A1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE049797T2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL185687A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007011129A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20074443L (cg-RX-API-DMAC7.html) |
| PL (1) | PL1869065T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1869065T (cg-RX-API-DMAC7.html) |
| RU (1) | RU2457214C2 (cg-RX-API-DMAC7.html) |
| SI (1) | SI1869065T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006099308A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0608584B8 (pt) * | 2005-03-11 | 2021-05-25 | Wyeth Corp | métodos de recuperar um produto purificado |
| EP2069387A4 (en) * | 2006-06-14 | 2011-02-02 | Glaxosmithkline Llc | METHODS OF PURIFYING ANTIBODIES USING HYDROXYAPATITE CERAMIC |
| JP2010501623A (ja) | 2006-08-28 | 2010-01-21 | アレス トレーディング ソシエテ アノニム | Fc含有タンパク質の精製法 |
| TW200821026A (en) * | 2006-09-08 | 2008-05-16 | Wyeth Corp | Arginine wash in protein purification using affinity chromatography |
| TW201516149A (zh) | 2006-09-13 | 2015-05-01 | Abbvie Inc | 細胞培養改良 |
| US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
| MX2009004974A (es) * | 2006-11-08 | 2009-05-20 | Wyeth Corp | Medios diseñado racionalmente para cultivo celular. |
| HUE024877T2 (en) | 2007-10-30 | 2016-02-29 | Genentech Inc | Antibody purification by cation exchange chromatography |
| US8093364B2 (en) | 2008-01-18 | 2012-01-10 | Bio-Rad Laboratories, Inc. | Enhanced purification of antibodies and antibody fragments by apatite chromatography |
| HUE066562T2 (hu) | 2008-08-14 | 2024-08-28 | Genentech Inc | Eljárások szennyezés eltávolítására indigén fehérje kiszorításos ioncserés membrán kromatográfia alkalmazásával |
| US20100069617A1 (en) * | 2008-09-12 | 2010-03-18 | Ge Healthcare Bio-Sciences Ab | Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions |
| WO2010030222A1 (en) * | 2008-09-12 | 2010-03-18 | Ge Healthcare Bio-Sciences Ab | Enhanced protein aggregate removal with multimodal anion exchangers in the presence of protein-excluded zwitterions |
| CA2932207A1 (en) * | 2008-10-20 | 2010-12-09 | Abbvie Inc. | Isolation and purification of antibodies using protein a affinity chromatography |
| CN104974251A (zh) | 2008-10-20 | 2015-10-14 | Abbvie公司 | 在抗体纯化过程中的病毒灭活 |
| RU2481824C2 (ru) | 2008-10-29 | 2013-05-20 | Аблинкс Н.В | Препараты однодоменных антигенсвязывающих молекул |
| CN105646643A (zh) | 2008-10-29 | 2016-06-08 | 阿布林克斯公司 | 单域抗原结合性分子的纯化方法 |
| KR20110086184A (ko) | 2008-12-22 | 2011-07-27 | 에프. 호프만-라 로슈 아게 | 면역글로불린 정제 |
| BR112012014937B1 (pt) * | 2009-12-18 | 2021-01-19 | Novartis Ag | método de produção de um anticorpo, fragmento de anticorpo ou proteína de fusão fc purificada usando uma matriz de cromatografia de afinidade |
| CA2787009C (en) | 2010-01-15 | 2018-04-03 | Bio-Rad Laboratories, Inc. | Surface neutralization of apatite |
| HRP20171095T4 (hr) | 2010-05-25 | 2022-07-22 | F. Hoffmann - La Roche Ag | Postupci pročišćavanja polipeptida |
| EP2583973B1 (en) * | 2010-06-21 | 2018-03-21 | Kyowa Hakko Kirin Co., Ltd. | Method for purifying protein using amino acid |
| GB201012603D0 (en) | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Protein purification |
| US9428546B2 (en) | 2010-07-30 | 2016-08-30 | Pfizer Inc. | Tandem purification of proteins |
| US8895707B2 (en) | 2010-08-18 | 2014-11-25 | Bio-Rad Laboratories, Inc. | Elution of proteins from hydroxyapatite resins without resin deterioration |
| JP2014503495A (ja) | 2010-11-15 | 2014-02-13 | バイオジェン アイデック インコーポレイテッド | 過負荷結合および溶出クロマトグラフィによる選択生成物アイソフォームの富化および濃縮 |
| JP5881744B2 (ja) | 2011-02-02 | 2016-03-09 | バイオ−ラッド ラボラトリーズ インコーポレーティッド | アルカリ溶液でのアパタイトの表面中和方法 |
| WO2012149197A2 (en) | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| CN103827134A (zh) | 2011-07-20 | 2014-05-28 | 泽普泰恩股份有限公司 | 多肽分离方法 |
| KR20140091721A (ko) | 2011-11-02 | 2014-07-22 | 제넨테크, 인크. | 오버로드 및 용리 크로마토그래피 |
| SG10201701224UA (en) | 2012-03-12 | 2017-04-27 | Merck Patent Gmbh | Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode |
| US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
| US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| US9249182B2 (en) * | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
| US9815695B2 (en) * | 2012-05-30 | 2017-11-14 | Bio-Rad Laboratories, Inc. | In situ restoration of apatite-based chromatography resins |
| SG11201407809QA (en) * | 2012-05-31 | 2014-12-30 | Agency Science Tech & Res | Chromatographic purification of immunoglobulin g preparations with particles having multimodal functionalities |
| HK1211981A1 (en) | 2012-09-02 | 2016-06-03 | Abbvie Inc. | Methods to control protein heterogeneity |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| JP6348507B2 (ja) | 2012-12-14 | 2018-06-27 | ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ | 充填ベッドクロマトグラフィーカラムの洗浄方法 |
| SG11201507230PA (en) | 2013-03-12 | 2015-10-29 | Abbvie Inc | Human antibodies that bind human tnf-alpha and methods of preparing the same |
| US10023608B1 (en) | 2013-03-13 | 2018-07-17 | Amgen Inc. | Protein purification methods to remove impurities |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| WO2014159579A1 (en) | 2013-03-14 | 2014-10-02 | Abbvie Inc. | MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE |
| PL3395423T3 (pl) * | 2013-03-14 | 2024-03-18 | Amgen Inc. | Usuwanie wypłukanych ligandów do oczyszczania na zasadzie powinowactwa |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| WO2014145744A1 (en) | 2013-03-15 | 2014-09-18 | Alder Biopharmaceuticals, Inc. | Antibody purification and purity monitoring |
| TWI596107B (zh) * | 2013-06-25 | 2017-08-21 | 卡地拉保健有限公司 | 單株抗體之新穎純化方法 |
| PL3044323T3 (pl) | 2013-09-13 | 2022-06-27 | F.Hoffmann-La Roche Ag | Sposoby wykrywania i ilościowego oznaczania białka komórki gospodarza w liniach komórkowych |
| SG11201601823TA (en) | 2013-09-13 | 2016-04-28 | Genentech Inc | Methods and compositions comprising purified recombinant polypeptides |
| US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| US9951101B2 (en) | 2013-12-12 | 2018-04-24 | Emd Millipore Corporation | Protein separations using an acrylamide containing filter |
| CN105392569B (zh) | 2014-06-23 | 2019-08-20 | 生物辐射实验室股份有限公司 | 磷灰石预处理 |
| EP3157863B1 (en) | 2014-06-23 | 2023-06-21 | Bio-Rad Laboratories, Inc. | Apatite in-situ restoration |
| WO2018022628A1 (en) | 2016-07-25 | 2018-02-01 | Cephalon, Inc. | Affinity chromatography wash buffer |
| US11155575B2 (en) | 2018-03-21 | 2021-10-26 | Waters Technologies Corporation | Non-antibody high-affinity-based sample preparation, sorbent, devices and methods |
| JP6951051B2 (ja) * | 2018-05-24 | 2021-10-20 | HOYA Technosurgical株式会社 | 吸着剤の生産方法 |
| US20220267369A1 (en) * | 2018-07-25 | 2022-08-25 | Merck Sharp & Dohme Corp. | Methods of separating host cell lipases from a production protein in chromatographic processes |
| WO2020172658A1 (en) | 2019-02-24 | 2020-08-27 | Bristol-Myers Squibb Company | Methods of isolating a protein |
| EP3941607A1 (en) | 2019-03-21 | 2022-01-26 | Codiak BioSciences, Inc. | Process for preparing extracellular vesicles |
| JP2023512991A (ja) * | 2020-01-29 | 2023-03-30 | メルク・シャープ・アンド・ドーム・エルエルシー | 抗lag3抗体生成からの宿主細胞リパーゼの分離方法 |
| WO2022066928A2 (en) | 2020-09-23 | 2022-03-31 | Codiak Biosciences, Inc. | Process for preparing extracellular vesicles |
| US20230366794A1 (en) | 2020-09-23 | 2023-11-16 | Codiak Biosciences, Inc. | Process for preparing extracellular vesicles |
| IL310556A (en) | 2021-08-23 | 2024-03-01 | Genentech Inc | Purification processes using cation exchange chromatography for drug-antibody conjugates |
| CA3236213A1 (en) * | 2021-10-27 | 2023-05-04 | Eugene ZURLO | Compositions and methods for isolating proteins |
| JP7820943B2 (ja) * | 2021-10-28 | 2026-02-26 | 花王株式会社 | Vhh抗体の製造方法 |
| US20260109751A1 (en) * | 2022-12-30 | 2026-04-23 | Eli Lilly And Company | Methods of dulaglutide purification using hydrophobic interaction chromatography |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4029583A (en) | 1975-02-28 | 1977-06-14 | Purdue Research Foundation | Chromatographic supports and methods and apparatus for preparing the same |
| JPS63126826A (ja) | 1986-11-14 | 1988-05-30 | Asahi Chem Ind Co Ltd | プラスミノ−ゲン活性化因子誘導物質 |
| US5451662A (en) * | 1987-10-23 | 1995-09-19 | Schering Corporation | Method of purifying protein |
| ATE121418T1 (de) * | 1987-10-23 | 1995-05-15 | Schering Corp | Verfahren zur proteinreinigung. |
| US4983722A (en) * | 1988-06-08 | 1991-01-08 | Miles Inc. | Removal of protein A from antibody preparations |
| ES2064412T3 (es) | 1988-10-26 | 1995-02-01 | American Cyanamid Co | Procedimiento para reducir el contenido de aglomerado de materiales tipo hormona del crecimiento. |
| GB9022547D0 (en) * | 1990-10-17 | 1990-11-28 | Wellcome Found | Purified immunoglobulin |
| US5264555A (en) | 1992-07-14 | 1993-11-23 | Enzon, Inc. | Process for hemoglobin extraction and purification |
| FR2703049B1 (fr) | 1993-03-22 | 1995-04-21 | Rhone Poulenc Rorer Sa | Procédé de purification des taxoïdes. |
| CA2106612C (en) | 1993-09-21 | 2001-02-06 | Diana Pliura | Displacement chromatography process |
| US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
| EP0701566A1 (en) * | 1994-04-01 | 1996-03-20 | Unisyn Technologies, Inc. | High salt binding buffer for immunoglobulin purification with a synthetic affinity ligand |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| RU2094077C1 (ru) * | 1996-07-23 | 1997-10-27 | Акционерное общество закрытого типа "Фосфосорб" | Хроматографический способ выделения альфа-фетопротеина |
| TW505655B (en) * | 1997-10-14 | 2002-10-11 | Tanox Inc | Enhanced aggregate removal from bulk-biologicals using ion exchange chromatography |
| US6504013B1 (en) | 2000-02-01 | 2003-01-07 | Idexx Laboratories, Inc. | Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody |
| WO2000015260A1 (en) | 1998-09-16 | 2000-03-23 | Tanox, Inc. | Anti-ige gene therapy |
| CA2356704A1 (en) | 1998-12-30 | 2000-07-13 | Folke Tjerneld | Separation method utilizing liquid-liquid partition |
| JP4363986B2 (ja) * | 2001-12-21 | 2009-11-11 | イミュネックス・コーポレーション | タンパク質の精製方法 |
| WO2004076485A1 (en) | 2003-02-28 | 2004-09-10 | Lonza Biologics Plc. | Antibody purification by protein a and ion exchange chromatography |
| GB0304576D0 (en) * | 2003-02-28 | 2003-04-02 | Lonza Biologics Plc | Protein a chromatography |
| JP4496168B2 (ja) * | 2003-07-28 | 2010-07-07 | 株式会社リバース・プロテオミクス研究所 | 非特異的物質の除去方法 |
| US7427659B2 (en) | 2003-10-24 | 2008-09-23 | Amgen Inc. | Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
| BRPI0415887B1 (pt) | 2003-10-27 | 2021-01-26 | Wyeth | métodos para a remoção de agregados de elevado peso molecular utilizando cromatografia de hidroxiapatita |
| BRPI0608584B8 (pt) | 2005-03-11 | 2021-05-25 | Wyeth Corp | métodos de recuperar um produto purificado |
-
2006
- 2006-03-10 BR BRPI0608584A patent/BRPI0608584B8/pt active IP Right Grant
- 2006-03-10 KR KR1020137028820A patent/KR101660575B1/ko not_active Expired - Lifetime
- 2006-03-10 CN CNA200680016391XA patent/CN101175765A/zh active Pending
- 2006-03-10 JP JP2008501028A patent/JP5199063B2/ja not_active Expired - Lifetime
- 2006-03-10 PT PT67380287T patent/PT1869065T/pt unknown
- 2006-03-10 US US11/372,054 patent/US8067182B2/en active Active
- 2006-03-10 AU AU2006223180A patent/AU2006223180B2/en not_active Expired
- 2006-03-10 ES ES06738028T patent/ES2797480T3/es not_active Expired - Lifetime
- 2006-03-10 DK DK06738028.7T patent/DK1869065T3/da active
- 2006-03-10 CN CN201410849296.4A patent/CN104610422A/zh active Pending
- 2006-03-10 MX MX2007011129A patent/MX2007011129A/es active IP Right Grant
- 2006-03-10 CA CA2601062A patent/CA2601062C/en not_active Expired - Lifetime
- 2006-03-10 WO PCT/US2006/008919 patent/WO2006099308A2/en not_active Ceased
- 2006-03-10 EP EP06738028.7A patent/EP1869065B1/en not_active Revoked
- 2006-03-10 HU HUE06738028A patent/HUE049797T2/hu unknown
- 2006-03-10 SI SI200632376T patent/SI1869065T1/sl unknown
- 2006-03-10 RU RU2007132851/10A patent/RU2457214C2/ru not_active Application Discontinuation
- 2006-03-10 KR KR20077020848A patent/KR101482791B1/ko not_active Expired - Lifetime
- 2006-03-10 PL PL06738028T patent/PL1869065T3/pl unknown
- 2006-08-28 US US11/510,634 patent/US20070054390A1/en not_active Abandoned
-
2007
- 2007-09-03 NO NO20074443A patent/NO20074443L/no not_active Application Discontinuation
- 2007-09-03 IL IL185687A patent/IL185687A/en active IP Right Grant
- 2007-09-12 CR CR9377A patent/CR9377A/es not_active Application Discontinuation
-
2011
- 2011-11-28 US US13/305,045 patent/US9144755B2/en active Active
-
2015
- 2015-11-12 HK HK15111155.1A patent/HK1210476A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL185687A0 (en) | A method of weak partitioning chromatography | |
| ZA200805297B (en) | Method of using ß-hydroxy-ß-methylbutyrate | |
| EP1954667A4 (en) | METHODS FOR SEPARATING PROPARGYL AMINOINDANES | |
| SG123650A1 (en) | Yield analysis method | |
| GB0400270D0 (en) | A method of authorisation | |
| EP1933309A4 (en) | SEARCH PROCESS | |
| GB0511639D0 (en) | Prediction method | |
| GB0509898D0 (en) | Analysis method | |
| IL208214A0 (en) | Methods for making 4-tetrazolyl-4-phenylpiperidine compounds | |
| GB2421949B (en) | Method of analyzing a protein | |
| GB0418529D0 (en) | Method for analysing | |
| HK1111705A (en) | A method of weak partitioning chromatography | |
| GB0511461D0 (en) | A method of analysis | |
| GB0501725D0 (en) | A method of analysis | |
| IL185801A0 (en) | Hydrocodone polymorphs | |
| EP1846854A4 (en) | METHOD FOR ANALYZING A PRODUCT | |
| GB0522644D0 (en) | New method for antagonisation of anticoagulants | |
| ZA200609731B (en) | A method of construction | |
| GB0414809D0 (en) | Analytical method | |
| GB0508747D0 (en) | A method of mounting windows | |
| GB0500240D0 (en) | New analytical method | |
| GB0510145D0 (en) | Method of analysis | |
| GB0511185D0 (en) | Method of analysis | |
| GB0502164D0 (en) | A method of providing a flanged component | |
| GB0512448D0 (en) | Improved seismic method |